Publications

Ndege R. Sero-negative HIV, a need for presumptive HIV diagnosis in adults in developing countries. HIV Med. 2024;25(2):306-307. DOI: 10.1111/hiv.13564

Anton-Vazquez V, Mnzava D, Okuma J, Mlembe S, Lo Riso L, Sanchez J.M, Ndege R, Vedastus Kalinjuma A, Kimera N, Eichenberger A, Nicoletti G.J, Wilson H, Vanobberghen F, Weisser M, KIULARCO Study Group. Improving anaemia diagnosis using peripheral blood smear with remote interpretation in adults living with HIV with moderate to severe anaemia: a prospective study nested within the Kilombero and Ulanga antiretroviral cohort. PLoS One. 2023;18(10):e0293084. DOI: 10.1371/journal.pone.0293084

Chuwa F, Kivuma B, Ndege R, KIULARCO Study Group. Repeated false-negative HIV rapid test results in a patient presenting to care with advanced HIV disease: a case report. IDCases. 2023;31:e01719. DOI: 10.1016/j.idcr.2023.e01719

Ndege R, Ngome O, Vanobberghen F, Bani F, Temba Y, Wilson H, Hella J, Gingo W, Sasamalo M, Mnzava D, Kimera N, Hiza H, Wigayi J, Mapesi H, Kato I.B, Mhimbira F, Reither K, Battegay M, Paris D.H, Weisser M, Rohacek M. Ultrasononography in managing extrapulmonary tuberculosis: a randomized, controlled, parallel, superiority, open-label trial. Clin Infect Dis. 2023;76(6):1013-1021. DOI: 10.1093/cid/ciac871

Ntamatungiro A.J, Eichenberger A, Okuma J, Vanobberghen F, Ndege R, Kimera N, Francis J.M, Kagura J, Weisser M, Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) Study Group. Transitioning to dolutegravir in a programmatic setting: virological outcomes and associated factors among treatment-naive patients with HIV-1 in the Kilombero and Ulanga Antiretroviral Cohort in rural Tanzania. Open Forum Infect Dis. 2023;10(7):ofad321. DOI: 10.1093/ofid/ofad321